Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Gaming addiction is expected to be classified as a mental disorder by the World Health Organisation (WHO) but – while concerns over the addictive properties of video games are reasonable – there is a lack of rigorous research to back it up.

Video games played on smartphones, tablets, computers and consoles have been a popular form of leisure for some time now. In Europe, recent figures indicate that games are played by more than two thirds of children and adolescents, and a substantial number of adults now play games – 38% in the UK, 64% in France, 56% in Germany and 44% in Spain.

The WHO will publish the next revision of its manual – the International Classification of Diseases (ICD-11) – by mid-2018 and gaming disorder has been included in the draft for the first time.

The ubiquity of mobile devices has means electronic games can be played at any time and their sales eclipse both music and video sales in the UK. Given the growing popularity and motivational pull of video games, concern over their addiction is inevitable.

Read the full article on The Conversation website, written by Amy Orben, Department of Experimental Psychology, and Andy Przybylski, Oxford Internet Institute. 

Oxford is a subscribing member of The ConversationFind out how you can write for The Conversation.    

Similar stories

Latest data on immune response to COVID-19 reinforces need for vaccination, says Oxford-led study

A new study led by the University of Oxford has found that previous infection, whether symptomatic or asymptomatic, does not necessarily protect you long-term from COVID-19, particularly against new Variants of Concern.

First trimester placental scan - Artificial Intelligence in Health and Care Award

A first trimester 3D placental ultrasound scan which can predict fetal growth restriction and pre-eclampsia, could become part of a woman's routine care thanks to a new Artificial Intelligence in Health and Care Award.

Impaired antibody response to COVID-19 vaccination in patients with myeloid blood cancers

Oxford researchers have found that antibody responses to the first doses of COVID-19 vaccine in people with chronic myeloid blood cancers are not as strong as those among the general population.

Treating Needle Fears May Reduce COVID-19 Vaccine Hesitancy Rates by 10%

A new large-scale study shows that a quarter of the UK adult population screens positive for a potential injection phobia.

RECOVERY trial Regeneron’s monoclonal antibody combination reduces deaths for hospitalised COVID-19 patients

The Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial has demonstrated that the investigational antibody combination developed by Regeneron reduces the risk of death when given to patients hospitalised with severe COVID-19 who have not mounted a natural antibody response of their own.

Major new study could help protect millions of people with type 2 diabetes from cardiovascular disease

A new study led by the Nuffield Department of Population Health at the University of Oxford will research whether a daily tablet could help protect the millions of people worldwide with type 2 diabetes from developing cardiovascular disease.